DICE Therapeutics, Inc.
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulat…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared DICE Therapeutics, Inc. (DICE) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 38,608.19 | 13,379.82 | 620.71 | 343.17 | -1,101.26 | 0.00 | 24.4590 | 43.70 | -0.7952 | -18.4898 | -0.07 | -0.07 | 5.9255 | - - | ||
| Maximum | - - | - - | - - | 1,535,067.00 | 609,984.00 | 35,800.00 | 99,050.00 | 5,421.00 | 0.02 | 1,336.3467 | 2,849.43 | 3.0051 | 85.3485 | 0.38 | 8.35 | 37.1953 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -164.8536 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0844 | - - | ||
| Karuna Therapeutics, Inc. KRTX | 329.83 | 0.09 0.03% | 1,283 vs. 971 | 12,599.00 | 0.00 | -113.00 | -111.00 | -997.00 | -3.0100 | -26.2644 | 0.0000 | 0.0000 | 0.0000 | -0.0908 | -0.0852 | 18.6075 | 38.00 | ||
| MoonLake Immunotherapeutics MLTX | 54.32 | 2.46 4.74% | 217 vs. 304 | 3,425.00 | 0.00 | -13.00 | -15.00 | -130.00 | -0.2200 | -55.6575 | 0.0000 | 0.0000 | 0.0000 | -0.0252 | -0.0242 | 61.5621 | 63.00 | ||
| Nuvalent, Inc. NUVL | 94.93 | 2.20 2.37% | 402 vs. 535 | 6,745.00 | 0.00 | -44.00 | -36.00 | -330.00 | -0.6900 | -27.7942 | 0.0000 | 0.0000 | 0.0000 | -0.0659 | -0.0628 | 20.6970 | 71.00 | ||
| Cytokinetics, Incorporated CYTK | 49.10 | 1.43 3.00% | 1,443 vs. 1,219 | 5,794.00 | 0.00 | -135.00 | -127.00 | -2,247.00 | -1.3300 | -13.7171 | 0.0000 | -1.7916 | -162.4467 | 0.3424 | -0.1679 | 6.9796 | 118.00 | ||
| Chinook Therapeutics, Inc. KDNY | 40.39 | 0.09 0.22% | 3,281 vs. 2,044 | 2,708.00 | 1.00 | -66.00 | -61.00 | -546.00 | -0.9400 | -10.2719 | 0.0000 | 0.5704 | -66.4127 | -0.1875 | -0.1370 | 5.7224 | 67.00 | ||
| DICE Therapeutics, Inc. DICE | 47.55 | 0.03 0.06% | 4,332 vs. 1,753 | 2,270.00 | 0.00 | -34.00 | -30.00 | -248.00 | -0.7400 | -15.7831 | 0.0000 | 0.0000 | 0.0000 | -0.0671 | -0.0632 | 25.6858 | 47.00 | ||
| Vaxcyte, Inc. PCVX | 88.54 | 0.15 0.17% | 1,609 vs. 1,242 | 11,035.00 | 0.00 | -95.00 | -171.00 | -1,019.00 | -0.8500 | -19.6094 | 0.0000 | 0.0000 | 0.0000 | -0.0479 | -0.0454 | 17.2498 | 124.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.